Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
Recruiting
N/A
Interventional Study
Gastroesophageal Reflux
Sleeve Gastrectomy
Bariatric Surgery Complication
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 200 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients \> 18 years
* BMI 30 or greater kg/m2
* Participants can give a consent to the procedure
* Participants have no contraindications to LSG (gastric ulceration)
Exclusion Criteria:
* Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stri…
Contacts